Real-World tracking of hemophilia drug safety and bleed control
NCT ID NCT02941783
Summary
This study monitored the safety and effectiveness of Kovaltry, a medication for hemophilia A, during routine medical use. Researchers followed 230 patients, including 50 children under 12, for up to two years to track side effects and how well the drug controlled bleeding episodes. The goal was to gather real-world information after the drug was approved for use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Many Locations
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.